7 unknown, 5 completed. 6 Phase 1, 3 Not applicable, 3 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 3, Unknown 3 |
| Not applicable | 3 | Unknown 3 |
| Phase 2 | 3 | Completed 2, Unknown 1 |
| Phase 3 | 2 | Completed 2 |
Follow Beijing Protgen Biotechnology Development Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With Ascites Recombinant Human Serum Albumin, Human Serum Albumin - Cirrhotic Ascites | Phase 2 / Phase 3 | Completed | Beijing Protgen Biotechnology Development Co., Ltd. | 390 | 2024-08-19 | 2026-03-10 |
| Phase II/III of Recombinant Human Serum Albumin Recombinant Human Serum Albumin, Human serum albumin - Cirrhotic Ascites | Phase 2 / Phase 3 | Completed | Beijing Protgen Biotechnology Development Co., Ltd. | 92 | 2023-05-24 | 2026-03-10 |
| Recombinant Human Serum Albumin in Patients With Liver Cirrhosis and Ascites Subjects Recombinant Human Serum Albumin, Human serum albumin - Hepatic Ascites | Phase 1 | Completed | Beijing Protgen Biotechnology Development Co., Ltd. | 36 | 2021-10-14 | 2026-03-11 |
| Recombinant Human Serum Albumin in Healthy Subjects recombinant human serum albumin, Human serum albumin - Hepatic Ascites | Phase 1 | Completed | Beijing Protgen Biotechnology Development Co., Ltd. | 48 | 2021-03-29 | 2026-03-11 |
| Clinical Trial of Quantitative Detection Kit for Hsp90α in Breast Cancer Hsp90 - Breast Cancer | Not applicable | Unknown | Beijing Protgen Biotechnology Development Co., Ltd. | 1100 | 2013-04-01 | 2014-12-24 |
| Clinical Trial of Quantitative Detection Kit for Hsp90α in Hepatic Cancer hsp90 - Liver Cancer | Not applicable | Unknown | Beijing Protgen Biotechnology Development Co., Ltd. | 1100 | 2012-10-01 | 2014-12-24 |
| Clinical Trial of Quantitative Detection Kit for Hsp90α in Colorectal Cancer Hsp90 - Colorectal Cancer | Not applicable | Unknown | Beijing Protgen Biotechnology Development Co., Ltd. | 1100 | 2012-09-01 | 2014-12-24 |
| Paclitaxel-Carboplatin Alone or With M2ES for Non-Small-Cell Lung Cancer pegylated endostatin and Paclitaxel-Carboplatin, Placebo and Paclitaxel-Carboplatin - Non Small Cell Lung Cancer | Phase 2 | Unknown | Beijing Protgen Biotechnology Development Co., Ltd. | 300 | 2011-05-01 | 2012-02-07 |
| Study of M2ES in Patients With Advanced Pancreatic Cancer After Gemcitabine Treatment Failure M2ES, M2ES 60mg - Pancreatic Cancer | Phase 1 | Unknown | Beijing Protgen Biotechnology Development Co., Ltd. | 24 | 2010-08-01 | 2010-10-28 |
| Study With M2ES and Gemcitabine for Patients With Advanced Pancreatic Cancer M2ES 7.5mg, M2ES 15mg, M2ES 30mg - Pancreatic Cancer | Phase 1 | Unknown | Beijing Protgen Biotechnology Development Co., Ltd. | 21 | 2010-06-01 | 2010-10-19 |
| Dose Escalation and PK Study of M2ES in Subjects With Advanced Solid Tumors M2ES 7.5mg, M2ES 15mg, M2ES 30mg - Advanced Solid Tumors | Phase 1 | Unknown | Beijing Protgen Biotechnology Development Co., Ltd. | 24 | 2009-09-01 | 2010-10-21 |
| Single-dose Escalation Trial of M2ES in Healthy Volunteer placebo, M2ES - Cancer | Phase 1 | Completed | Beijing Protgen Biotechnology Development Co., Ltd. | 33 | 2009-05-01 | 2010-10-19 |
Neoplasms (2) · Pancreatic Neoplasms (2) · Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Liver Neoplasms (1)
Serum Albumin, Human (4) · recombinant human serum albumin-heme (4) · CP protocol (1) · Methods (1)
China (11)
Jidong Jia, Ph.D (2) · Bei Hu, Ph.D (1) · Jinming Yu, MD (1) · Li Zhang, master (1) · Rui Chen, Ph.D (1) · Shusen Zhen, MD (1) · Yan Sun, MD (1) · Zhaosheng Li, MD (1) · Zhongsheng Tong, MD (1)